Alexandra Balcom serves as Executive at Nuvalent, Inc., where they oversee executive responsibilities. Since joining the company, Alexandra Balcom has executed 59 insider transactions totaling $19.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 31, 2024 involved selling 597 shares valued at $46.6K.
Alexandra Balcom currently holds 89,150 shares of Nuvalent, Inc. (NUVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alexandra Balcom has been a net seller of NUVL stock. They have purchased $0 and sold $19.0M worth of shares.
Alexandra Balcom's most recent insider trade was on Jul 31, 2024, when they sold 597 shares at $78.05 per share.
Get notified when new Form 4 filings are submitted
| $77.02 |
| Planned |
| Jul 31, 2024 | NUVL | $454.6K | Sale | 5,723 | $79.44 | Planned |
| Jan 5, 2024 | NUVL | $0 | Award | 33,300 | $N/A | Discretionary |
| Dec 18, 2023 | NUVL | $32.4K | Option Exercise | 30,000 | $1.08 | Discretionary |
| Dec 18, 2023 | NUVL | $2.3M | Sale | 30,000 | $75.82 | Discretionary |
| Jul 31, 2023 | NUVL | $536.9K | Sale | 10,848 | $49.49 | Planned |
| Jul 31, 2023 | NUVL | $687.9K | Sale | 14,152 | $48.61 | Planned |
| Jul 31, 2023 | NUVL | $27.0K | Option Exercise | 25,000 | $1.08 | Planned |